The conference will start on Wednesday 21st September with a welcome lunch and end on Friday 23rd at noon.
Ion channels are a family of ubiquitous proteins with an extraordinary diversity of their molecular and cellular functions, their structure or their expression. This diversity is also represented in the pathological disorders where ion channels are associated with.
Indeed, aberrant function or dysfunction of ion channels have been associated to a large spectra of diseases such as neurological and cardiovascular disorders, diabetes, metabolic diseases but also cancer, a highly metabolic disease.
While the contribution of ion channels to cancers is now beyond the reasonable doubt, their molecular function in those pathological processes solely begin to be understood.
In particular, recent advances suggest that ion channels could have an important role in the relationship of cancer cells with their surrounding environment and in metabolic changes occurring during cancer development. To elucidate the molecular function of ion channels and to potentially use them as therapeutic target, innovative tools will be required.
This LE STUDIUM Conference aims to provide an overview of the state-of-the-art of the physio-pathological role of ion channels, with a special emphasis on cancers, and of the new innovative tools in development for their investigation or their targeting.
Topics
- Ion channels
- Cancers
- Physiopathology
- Molecules design
- Biotechnology
Convenors
- Dr David Crottès, LE STUDIUM Research Fellow
FROM: University of California San Francisco - USA
IN RESIDENCE AT: Nutrition, Growth and Cancer (N2C) / INSERM, University of Tours - FR - Prof. Christophe Vandier,
Nutrition, Growth and Cancer (N2C) / INSERM, University of Tours - FR - Prof. Stéphane Petoud,
Center for Molecular Biophysics (CBM) / CNRS - FR
Slideshow
